Shalin Shah, CEO of Marius Pharmaceuticals and developer of KYZATREX®, dives into the world of testosterone therapy. He addresses common myths surrounding testosterone and emphasizes its vital role in both men's and women's health. Shalin highlights the transformative potential of oral testosterone, advocating for its accessibility and effectiveness compared to traditional injections. The conversation also covers the metabolic benefits of testosterone and the need for standard testing practices, reshaping our understanding of hormone health.

Join Shalin Shah, CEO of Marius Pharmaceuticals and innovator behind Kyzatrex, an oral testosterone therapy that minimizes liver toxicity. He shares his journey from finance to health, illuminating how Kyzatrex's unique lymphatic absorption method offers safer alternatives for testosterone treatment. They tackle the side effects of traditional therapies, discuss patient education's role, and delve into the Testosterone Project's mission to improve access and understanding of hormone therapy. A groundbreaking conversation for anyone interested in the future of testosterone care.